Delivery Order SPE2DB20D1100-SPE2DB25FD6P1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for supply of Journavx 50 mg tablets (30-count packaging) valued at $3,048.36. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Journavx 50 mg tablets (30-count units) valued at $1,561.55. This non-set-aside, competitively awarded contract employs firm fixed pricing and carries an ultimate completion date of August 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This delivery order, valued at $5,998.20, was awarded to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Journavx 50 mg tablets (30-count units) to support federal medical procurement needs. The contract represents a non-competitive, firm fixed-price delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical, a $999.99 billion prime contract vehicle designated SPE2DX and running through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,269.06 to AmerisourceBergen Drug Corp for JOURNAVX 50 MG tablets (30-count supply), with an ultimate completion date of September 17, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. AmerisourceBergen Drug Corp,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,296.75 by the Defense Logistics Agency's Medical Supply Chain on July 16, 2025, with an ultimate completion date of July 17, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,035.44 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price, non-set-aside delivery order represents a small-value transaction under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,585.45 by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, classified as a child contract with no set-aside designation, is for pharmaceutical products and medical supplies to be delivered to Conshohocken, Pennsylvania. The award represents a competitive procurement action, consistent with AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $1,662.05 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, with completion scheduled for July 29, 2025. This non-set-aside award represents a child contract under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6P1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal procurement requirements for pharmaceutical products. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DLA Troop Support is strategically planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards across at least three contractors, positioning AmerisourceBergen as a critical vendor within this evolving procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |